FINHUB Insights

CAH · Q2 FY26 · Oct 1 – Dec 31, 2025

Cardinal Health Q2 FY26: where the revenue came from and where it went

Cardinal Health Q2 FY26: revenue $65.6B (+19% year over year). Net profit $0.5B. Largest cohort Pharmaceutical and Specialty $56.1B. The whole income statement as a sankey diagram from the SEC filing.

Period
Oct 1 – Dec 31, 2025
Reported
Apr 30, 2026 10-Q
Sankey diagram of Cardinal Health's income statement for Q2 FY26: revenue of $65.6 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$65.6B +19% year over year
Gross profit$2.4B 4% margin
Operating profit$0.7B 1% margin
Net profit$0.5B 1% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Dec 31, 2025).
ItemValueShare of revenueYear over year
Revenue 65.6 100% +19%
Pharmaceutical and Specialty 56.1 86% +10%
Other 6.1 9%
Other Segments 1.7 3%
at-Home Solutions 1.1 2% +35%
Nuclear Precision Health 0.5 1% +28%
OptiFreight Logistics 0.1 0% +32%
Cost of revenue−63.296%
Gross profit2.44% margin+0pp
SG&A−1.52%+0pp
Other−0.20%+0pp
Operating profit0.71% margin+0pp
Tax−0.1
Interest & other costs−0.1
Net profit0.51%+0pp
Filing on EDGAR More quarters of CAH

Source of the numbers: tables in the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters